Related Experiment Video
Updated: Oct 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis: diagnosis and management
1Department of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida 32610-0284, USA. tbhatti@eye1.eye.ufl.edu
Abstract:
Visual loss caused by giant cell arteritis is a medical emergency that requires prompt recognition and treatment with systemic corticosteroids. A delay in diagnosis can lead to devastating ophthalmic and systemic complications. Recent advances in genetic and immunocytochemical research techniques have led to greater understanding of the underlying pathomechanisms of giant cell arteritis. Giant cell arteritis is a systemic condition with a strong predilection for the ocular vasculature. Visual symptoms are often the presenting manifestation of the disease, placing the ophthalmologist in a critical position for early diagnosis and treatment. Maintenance of a high clinical suspicion in the appropriate clinical setting is important in establishing an early diagnosis. Because of the complex nature of the disease process, many cases may be a therapeutic challenge requiring prolonged immunosuppression.
Related Concept Videos
Aneurysm III: Interprofessional Care
Rheumatic Heart Disease III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Atherosclerosis III: Management
Aortic Regurgitation III: Medical Management